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Phosphodiesterase activities for adenosine and guanosine 3’ : 5’-monophosphates (cyclic AMP 
and cyclic GMP) were demonstrated in particulate and soluble fractions of rat anterior 
pituitary gland. Both fractions contained higher activity for cyclic GMP hydrolysis than that for 
cyclic AMP hydrolysis when these activities were assayed at subsaturating substrate concentra- 
tions. Addition of protein activator and CaCl, to either whole homogenate, particulate or 
supernatant fraction stimulated both cyclic AMP and cyclic GMP phosphodiesterase activities. 
Almost 80% of cyclic AMP and 90% of cyclic GMP hydrolyzing activities were localized in 
soluble fraction. Particulate-bound cyclic nucleotide phosphodiesterase activity was completely 
solubilized with 1 % Triton X-100. Detergent-dispersed particulate and soluble enzymes were 
compared with respect to CaZ + and activator requirements and gel filtration profiles. 
Particulate, soluble and partially purified phosphodiesterase activities were also characterized 
in relation to divalent cation requirements, kinetic behavior and effects of Ca2+, activator 
and ethyleneglycol-bis-(2-aminoethyl)-N,N’-tetraacetic acid. Gel filtration of either sonicated whole 
homogenate or the 105000xg supernatant fraction showed a single peak of activity, which 
hydrolyzed both cyclic AMP and cyclic GMP and was dependent upon Ca2+ and activator for 
maximum activity. Partially purified enzyme was inhibited by 1-methyl-3-isobutylxanthine and 
papaverine with the concentration of inhibitor giving 50% inhibition at 0.4 pM substrate 
being 20 pM and 24 pM for cyclic AMP and 7 pM and 10 pM for cyclic GMP, respectively. 
Theophylline, caffeine and theobromine were less effective. The rat anterior pituitary also contained 
a protein activator which stimulated both pituitary cyclic nucleotide phosphodiesterase(s) as well 
as activator-deficient brain cyclic GMP and cyclic AMP phosphodiesterases. Chromatography of 
the sonicated pituitary extract on DEAE-cellulose column chromatography resolved the phos- 
phodiesterase into two fractions. Both enzyme fractions hydrolyzed cyclic AMP and cyclic GMP 
and had comparable apparent K, values for the two nucleotides. Hydrolysis of cyclic GMP and 
cyclic AMP by fraction I1 enzyme was stimulated 6-7-fold by both pituitary and brain 
activator in the presence of micromolar concentrations of Ca2+. 
In most biological systems intracellular levels of 
cyclic AMP are regulated by the relative activities of 
hormone-responsive adenylate cyclase and cyclic 
AMP phosphodiesterase. Similarly, concentration of 
cyclic GMP is also maintained by relative activities 
of guanylate cyclase and cyclic GMP phosphodi- 
esterase. Cyclic nucleotide phosphodiesterases are 
present in both cytoplasmic and particulate fractions 
of the cell [l - 51 and in many tissues exists at least 
Abbreviations. EGTA, ethyleneglycol-bis-(2-aminoethyl)-N,N’- 
tetraacetic acid; cyclic AMP, adenosine 3’: 5’-monophosphate; 
cyclic GMP, guanosine 3’: 5’-monophosphate. 
Enzyme. 3’: 5’-Cyclic-AMP phosphodiesterase (EC 3.1.4.17). 
in two or more molecular forms [l - 151. Recent reports 
have described the existence of a protein modifier for 
cyclic nucleotide phosphodiesterases which require 
Ca2+ as cofactor [16-181. 
In rat anterior pituitary gland cyclic AMP pre- 
sumably acts as a second messenger [19,20] in gonado- 
liberin-induced lutropin release. This effect is also 
mediated by Ca2+ [20,21]. In order to understand the 
role of Ca2+ and cyclic AMP in gonadoliberin- 
induced lutropin release, the degradation of cyclic 
AMP by phosphodiesterase and involvement of Caz + 
in this process were studied. Only in one instance 
high K,,, cyclic AMP phosphodiesterase has been 
measured in rat anterior pituitary during development 
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[22]. In view of the biologically important role of the 
cyclic nucleotide phosphodiesterases in determining 
the intracellular level of cyclic AMP [23] we have 
attempted to characterize the multiple forms of these 
enzymes in rat anterior pituitary with respect to 
substrate specificity, Ca2 +-dependence and activator 
requirement. Since current evidence suggests that in 
some systems cyclic GMP might play a critical role 
as a second messenger distinct from cyclic AMP [24] 
we also studied cyclic GMP phosphodiesterase in our 
system. 
MATERIALS AND METHODS 
Materials 
[3H]Adenosine 3' : 5'-monophosphate (specific 
activity 26 Ci/mmol) and [3H]guanosine 3' : 5'-mOnO- 
phosphate (specific activity 19 Ci/mmol) were obtained 
from New England Nuclear. Both cyclic nucleotides 
were purified by Dowex-I (X-8; 200-400 mesh; C1- 
form) column chromatography as described by Kakui- 
chi etal. [13]. Unlabelled cyclic GMP, cyclic AMP, 
papaverine, caffeine, theobromine, theophylline and 
snake venom (Crotalus atrox) were all obtained from 
Sigma Chemical Co. The 3-isobutyl-1-methylxanthine 
was supplied by Aldrich Chemical Co. Anion exchange 
resin (Bio-Rad AG1 X-2; 200-400 mesh) and agarose 
gel (Bio-Gel A-5m, 100 - 200 mesh) were purchased 
from Bio-Rad Laboratories. EGTA was a product 
from Sigma Chemical Co. All other reagents used 
were of analytical grade. All the solutions were 
prepared in deionized water. 
Preparation of Pituitary Extract 
25 - 26 day-old female rats (Spartan) were killed 
by decapitation under chloroform anaesthesia. Ante- 
rior pituitaries were immediately removed and col- 
lected in normal saline. Pituitaries (usually sixty) 
were homogenized unless otherwise stated in a glass 
homogenizer in 4 ml of buffer (10 mM Tris-HC1, 
pH 7.5, 1 mM MgCl,, 0.1 mM EGTA, 3.75 mM 
2-mercaptoethanol). The homogenate was usually 
centrifuged at 105000 x g for 60 min. The super- 
natant thus obtained was either subjected to gel 
filtration or dialyzed overnight against 2 1 of the 
above buffer for 24 h at 0-4 "C (four changes of 
buffer). The sediment, where required, was also 
suspended in 4ml  of the above buffer and dialyzed 
exactly as described above. In some cases whole 
homogenate was sonicated under the conditions 
described by Thompson and Appleman [2] and 
centrifuged at 20000 x g for 20 min. The supernatant 
was then subjected to gel filtration as described 
below. 
Agarose-Gel Filtration 
Gel filtration on Bio-Gel-A 5m was performed 
according to Thompson and Appleman [3] in columns 
(2.5 x 45 cm) at flow rates of 10- 12 ml per h at 
0-4 "C. The elution medium contained 50 mM Tris- 
HCl buffer, pH 7.5, 100 mM NaC1, 1 mM MgCl,, 
3.75 mM 2-mercaptoethanol and 0.1 mM EGTA. 
Fractions of 64 drops ( % 4 ml) were collected and 
assayed either in the presence of 100pM EGTA or 
100 pM CaCl, and saturating concentration rat brain 
activator [17]. 
DEAE-Cellulose Column Chromatography 
Chromatography on DEAE-cellulose (DE52) was 
carried out in columns (1.2 x 10 cm) equilibrated with 
50 mM sodium acetate, pH 6.5, containing 5 mM 
2-mercaptoethanol. Sonicated extract (1 ml) was ap- 
plied to the column and washed with 60ml of the 
column buffer. A linear gradient from 0.07 M to 1 M 
sodium acetate (100ml each) was then applied and 
forty-drop (2.5 ml) fractions were collected. The frac- 
tions were then assayed for cyclic AMP and cyclic 
GMP phosphodiesterases in the presence and absence 
of activator. 
Preparation of Activator 
A heat-stable, non-dialyzable activator of phos- 
phodiesterase from either brain or anterior pituitaries 
was prepared according to Cheung [16]. Briefly, tissue 
samples were homogenized in 3 volumes of distilled 
water at 0-4 "C. The homogenate was adjusted to 
pH 5.9 and centrifuged at 13000 x g for 30 min. The 
sedimented material was discarded. The supernatant 
was next heated in boiling water bath for 5 min and 
after this treatment was transferred to an ice bath. 
After centrifugation the clear supernatant was dialyzed 
successively against two changes (200 volumes) of 
10 mM Tris-HC1 buffer, pH 7.5, containing 1 mM 
MgC1, and 0.1 mM EGTA for 24 h and then against 
three changes (400 volumes) of 10 mM Tris-HC1, 
pH 7.5, for an additional 48 h. Assay for activator 
was performed according to Kakuichi et al. [17] based 
on the ability of the activator to enhance the activity 
of diluted 105000 x g supernatant fraction of rat 
brain homogenate in the presence of 0.1 mM CaC1,. 
The amount of the activator that doubled the enzyme 
activity in the standard assay system is defined as 
10 units. 
Assay of Phosphodiesterase 
The enzyme assay was carried out according to the 
procedure of Thompson and Appleman [2] as modified 
by Boudreau and Drummond [25]. The procedure 
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involved the conversion of 5'-AMP (or GMP), the 
end product of cyclic AMP (or cyclic GMP) phos- 
phodiesterase reaction, to adenosine (or guanosine) by 
5'-nucleotidase (snake venom) and the subsequent 
separation of the substrate and final product by 
cation-exchange resin. Assay mixture in a final 
volume of 200 pl contained 10 mM Tris-HC1, pH 7.5, 
1 mM MgCl,, 3.75 mM 2-mercaptoethanol, cyclic 
[3H]AMP (or GMP) (120 x 1000 counts/min) unlabel- 
led cyclic AMP (or GMP) 0.2 pM (low substrate) or 
200 pM (high substrate) and suitably diluted enzyme. 
In addition, 100 pM CaC1, and 10-30 pg of activator 
were also added where required. After incubation at 
20 "C for usually 5 min the reaction was stopped by 
placing the tubes first in solid CO,/ethanol bath and 
then by boiling in a water bath for 3 min. 50 pl of snake 
venom (1 mg/ml) were added to each tube and incuba- 
tion continued at 20 "C for 10 min. The reaction was 
stopped by the addition of 1 ml of resin (2 parts 
3 mM acetic acid, 1 part resin in the case of cyclic 
AMP or 3 parts 11 5 mM formic acid, 1 part resin in the 
case of cyclic GMP) and the contents spun at 2000 x g 
for 5 min and 0.5 ml aliquots counted for radioactivity 
in a Beckman LS230 spectrophotometer. 
Protein Determinations 
Protein was determined by the colorimetric proce- 
dure of Lowry et al. [26] using bovine serum albumin 
as standard. 
RESULTS 
Kinetic Properties of Crude Phosphodiesterase(s) 
Results presented in Fig. 1 show kinetic behavior 
of sonicated supernatant fraction. When the apparent 
K, was determined using a wider range of substrate 
concentration, the Lineweaver-Burk plot was not 
linear. Extrapolation of the linear portions of these 
plots showed two apparent K ,  values (Table 1). The 
particulate free supernatant and 105000 x g sediment 
exhibited similar apparent K ,  values (Table 1). 
Cyclic GMP phosphodiesterase activity in the son- 
icated fraction (Fig.l), soluble fraction as well as 
particulate fraction (105000 x g) ,  showed straight- 
forward kinetic behavior with an apparent K, of 
7 - 20 pM (Table 1). 
Fractionation of Anterior Pituitary Cyclic Nucleotide 
Phosphodiesterases by Gel Filtration 
Cyclic nucleotide phosphodiesterase was partially 
purified by agarose A-5m column chromatography. 
Fig.2 shows a typical elution profile of cyclic GMP 
phosphodiesterase from sonicated 20000 x g super- 
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Fig. 1. Kinetic analysis by double reciprocal plot of cyclic A M P  and 
cyclic GMP hydrolysis by rat anterior pituitary sonicared super- 
natant. Concentrations of cyclic AMP ranged from 0.14 pM to 
25 pM and cyclic GMP from 0.15 1M to 25 pM. The results are 
mean of duplicate samples 
Table 1 .  Apparent K, values of the particulate and soluble cyclic 
nucleotide phosphodiesterases 
Anterior pituitaries from thirty rats were homogenized in 7.2 ml 
of buffer (20 mM Tris-HC1, pH 7.4; 3.75 mM 2-mercaptoethanol) 
and homogenate was divided into two parts. The first part 
(3.6 ml) was sonicated 10 rnin at 0-4 "C and then centrifuged at 
20000 x g for 20 min. The clear supernatant was used for enzyme 
assays. The second part was directly centrifuged at 105000 x g for 
60 min and the clear supernatant saved. The sediment was rinsed 
with buffer and resuspended in 3.6 ml of buffer. The supernatant, 
sediment and sonicated fractions were tested for nucleotide 
phosphodiesterase activity. Concentrations of cyclic AMP ranged 




low high cyclic GMP 
Sonicated Extract 0.67 20 7 
Sediment (105000 xg) 0.33 13 20 
Supernatant(105000xg) 1.80 20 10 
natant. The peak activity was stimulated almost 
3-fold by 100 pM CaC1, and to about 6-fold in the 
presence of activator and CaCl,. Similar results were 
also obtained using cyclic AMP (0.4 pM). By this 
procedure although separation of cyclic AMP and 
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Fig.2. Agarose A-5m gel filtration profile of the pituitary phos- 
phodiesterase from sonicated supernatant. Four ml of the sonicated 
extract (30 pituitaries) was applied on the column (2.5 x 45 cm) and 
eluted with 50 mM Tris-HC1, pH 7.5, containing 10 mM NaC1, 
1 mM MgCI,, 3.75 mM 2-mercaptoethanol and 0.1 mM EGTA. 
The flow rate was 12 ml/h and 4.1-ml (64 drops) fractions were 
collected. Cyclic GMP (0.4 pM) was used to monitor phosphodi- 
esterase activity. (O..-. O), No additions; (*---a), CaCI, 100 pM; 
(A-A), CaC1, 100 pM + activator 28 pg; (-) absorbance at 
280 nm 
cyclic GMP phosphodiesterases could not be achieved, 
it did purify both activities between 10 - 15-fold with 
30 - 40% recovery. The concentrated prepara- 
tion or column eluate containing 1 mg/ml albumin 
were stable for a few weeks at -20 "C. Results pre- 
sented in Fig. 3 show the elution profile of particulate 
free supernatant on agarose columns. Both the activ- 
ities were eluted in the same position as in the 
case of sonicated extract. Measurement of activities 
in the presence of 100 pM EGTA or 100 pM CaCl, 
and activator did not affect the elution profile. Similar 
results were also obtained using higher concentrations 
(200 pM) of either cyclic AMP or cyclic GMP. 
PROPERTIES OF PARTIALLY PURIFIED ENZYME 
K, for Cyclic GMP and Cyclic AMP 
Lineweaver-Burk plots of the rates of hydrolysis 
of cyclic GMP by partially purified enzyme either 
in the presence or absence of activator and 100pM 
CaCl, gave a straight line with an apparent K, 
of 8 pM. The presence of activator did not change the 
K,, but it increased V. When K, determinations were 
carried out in the presence of 100 pM EGTA the Line- 
weaver-Burk plots showed two K, values of 1 pM and 
20 pM. Identical results were obtained when cyclic 
GMP was used as substrate (Table 2). 
Effect of Activator, CaCl, and EGTA 
The effect of EGTA on pituitary cyclic nucleotide 
phosphodiesterases is shown in Table 3. In the 
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Fig. 3. Agarose A-5m gel filtration of the particulate free pituitary 
supernatant. Experimental conditions were identical to those 
described under Fig.2. Each fraction was assayed for cyclic 
AMP(A) and cyclic GMP (B) phosphodiesterase activities in the 
presence and absence of activator. The concentration of substrates 
used was 0.4 pM. (w), Activator 28 pg + CaC1, 100 pM; 
(0-o), EGTA 0.1 mM 
Table 2. Effect of activator on EGTA on the K, ofpartially purified 
cyclic A M P  and cyclic GMP phosphodiesterases 
Partially purified enzyme was obtained by agarose A-5m gel 
chromatography as described in the text. The active fractions were 
pooled and dialyzed for 24 h against four changes of buffer 
(20 mM Tris-HC1, pH 7.4; 3.75 mM 2-mercaptoethanol). After 
dialysis the samples were assayed for cyclic AMP and cyclic GMP 
phosphodiesterases in the presence of activator (28 pg protein) and 
EGTA (0.1 mM). Other details were the same as described under 
Table 1 
Treatment K m  
cyclic AMP cyclic GMP 
None 5.7 8 
EGTA (0.1 mM) 0.5,3.6 1,20 
Activator 
(28 pg) + CaCI, (0.1 mM) 5.7 8 
presence of excess M$ + , EGTA (100 pM) inactivated 
the activator deficient cyclic AMP and cyclic GMP 
phosphodiesterases to about 67 - 72%, respec- 
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Table 3. Effect of EGTA, activator and CaCI, on partially purified cyclic nucleotide phosphodiesterase 
Partially purified enzyme was obtained as described under Table 1. The active fractions were dialyzed against four changes of buffer 
(20 mM Tris-HC1, pH 7.4; 3.75 mM 2-mercaptoethanol). After dialysis samples were assayed for cyclic AMP and cyclic GMP 
phosphodiesterases as described in the text. The concentration of substrate used was 0.4 pM 
Additions Cyclic AMP hydrolyzed Cyclic GMP hydrolyzed 
pmol x min-' x mg protein-' 
None 
CaC1,lOO pM 
Activator (28 pg) 
EGTA 100 pM 
CaCl, 100 pM + activator (28 pg) 
CaCI, 100 pM + EGTA 100 pM 
Activator (28 pg) + EGTA 100 pM 


















tively, whereas in the presence of saturating concentra- 
tions of protein activator, the enzyme activities were 
stimulated five fold and eight-fold. Addition of 
100 pM CaC12 along with activator further increased 
the enzyme activity that was observed without added 
divalent metal ion. The activation of cyclic nucleotide 
phosphodiesterase by protein activator was completely 
abolished by low concentrations of EGTA in the 
presence of excess M$+. In the absence of activator 
and chelating agent 100pM Ca" alone did not 
activate enzyme activity more than 5-10%. These 
results indicate that the activation of cyclic AMP and 
cyclic GMP phosphodiesterases in the pituitary 
requires the presence of both protein activator and 
Ca2 + . 
Effect of Divalent Metal Ions 
Effect of divalent cations on cyclic GMP and cyclic 
AMP phosphodiesterase activities present in the partic- 
ulate free and sediment fractions are given under 
Fig. 4. Cyclic AMP and cyclic GMP phosphodiesterase 
activities in dialyzed particulate, supernatant and 
partially purified (by agarose column chromato- 
graphy) fractions were detectable without added metal 
ions and these activities were stimulated by the 
activator. Both Mg2+ and Mn2+ stimulated the 
activities with increasing concentrations of divalent 
metal ions both in the presence and absence of added 
activator. The overall stimulation in the case of 
dialyzed particulate or soluble fraction was higher 
when Mg2+ was used as the metal ion compared to 
Mn2+ (Fig.4A-D). Ca2+, on the other hand, either 
slightly stimulated enzyme activities or had no effect 
on the concentrations tried both in the presence or 
absence of activator. 
Partially purified cyclic nucleotide phospho- 
diesterase in the presence or absence of added activator 
hydrolyzed both cyclic AMP and cyclic GMP in the 
absence of added metal ion. Addition of activator 
itself increased the hydrolytic activities about eight- 
fold and six-fold respectively, when enzyme activities 
were tested against cyclic AMP and cyclic GMP 
(Fig.4E,F). The effect of Mn2+ on partially purified 
enzyme was different with the cyclic AMP and 
cyclic GMP as substrates. Cyclic AMP hydrolysis in 
the presence of added activator and Mn2+ was much 
higher than that in the presence of Mg2 + at low concen- 
trations, but in the case of cyclic GMP both metal ions 
were almost equally effective. Ca2+, as in the case 
of particulate or soluble enzyme also did not signifi- 
cantly stimulate partially purified activity. 
Effect of Inhibitors 
The effect of phosphodiesterase inhibitors on 
partially purified enzyme is shown in Fig. 5 and Table 4. 
Papaverine and 1-methyl-3-isobutylxanthine were 
more effective than caffeine and theophylline. Theo- 
phylline was more potent compared to caffeine and 
theobromine (Fig. 5). The concentration of l-methyl- 
3-isobutylxanthine and papaverine required to produce 
50 percent inhibition was 21 and 24 pM for cyclic 
AMP and 7 and 10 pM for cyclic GMP, respectively 
(Table 4). Other inhibitors required higher concentra- 
tions to produce similar inhibition. 
Separation of Cyclic Nucleotide Phosphodiesterase 
by DEAE-Cellulose Column Chromatography 
The elution profile of sonicated pituitary extracts 
on DEAE-cellulose column is shown in Fig. 6. Follow- 
ing chromatography, phosphodiesterases were 
resolved into one minor (I) and one major (11) peaks 
and hydrolyzed both cyclic AMP and cyclic GMP. 
When higher cyclic AMP concentrations (100 pM) 
were utilized, only one peak of activity was observed 
(Fig. 6C) which coincided with peak I1 activity 
(Fig.6A, B). In all the cases peak I1 was greatly 
stimulated by protein activator (5 - 7-fold). 
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Fig. 4. Effect of divalent metal ions on particulate, soluble and partially purified phosphodiesterases. Fifty pituitaries were homogenized in 
4 ml of buffer (10 mM Tris-HCI, pH 7.5, 1 m M  MgCI,, 0.1 mM EGTA, 3.75 mM 2-mercaptoethanol) and homogenate was 
centrifuged at 105000 x g for 60 min to isolate particulate-free supernatant and sediment fractions. Both fractions were dialyzed 
against buffer for 24 h as described under Materials and Methods. Partially purified enzyme was obtained by gel filtration as described under 
Table 2 and was dialyzed. All the fractions were then tested for cyclic G M P  and cyclic A M P  hydrolysis in the presence and absence 
of activator and various divalent metal ions. All solutions of divalent metal ions were prepared in deionized water as suggested by 
Lin etal. [27]. (AV) N o  metal ion; (0-0, A---A) M n Z + ;  (0-0,O-0) Mg”; (H, M) C a Z + ;  (U. o--O. M. A) 
with activator; (A---A, 0-0. M, V) without activator; (A,B) particulate free supernatant; (C,D) sediment (105000 x g ) ;  
(E,F) partially purified enzyme; (A,C,E) cyclic A M P  hydrolysis; (B,D,F) cyclic G M P  hydrolysis 
Peak I with cyclic AMP gave two K, values of 
1.5 pM and 13 pM while with cyclic GMP it gave 
essentially straight kinetic plots with apparent K, of 
10 pM in the presence of saturating concentrations of 
activator. Peak I1 showed straight kinetic plots with 
both cyclic AMP and cyclic GMP with apparent K, 
values of 5 pM and 10 pM, respectively. 
Effect of Different Protein Activators 
on the Peak I I  Phosphodiesterase Activity 
Using both low (0.4 pM) and high (100 pM) cyclic 
AMP peak 11 phosphodiesterase activity was stimu- 
lated about 5-fold in the presence of brain activator 
and about 6-fold in the presence of pituitary activator 
(Table 5).  Both activators almost equally stimulated 
cyclic GMP hydrolysis. 
Apparent Distribution of Cyclic Nucleotide 
Phosphodiesterase in Soluble and Particulate Fractions 
In addition to characterization of soluble enzyme 
attempts were also made to follow the distribu- 
tion of phosphodiesterase in particulate and soluble 
fractions and solubilization of the particulate enzyme. 
Results presented in Table 6 show the distribution of 
cyclic AMP and cyclic GMP phosphodiesterases be- 
tween 105 000 x g sediment and particulate fractions. 
Almost 80% of cyclic AMP hydrolyzing activity was 
confined to the supernatant fraction. In contrast, 
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Fig. 5. Effeeci of inhibitors on partially purified phosphodiesterases. 
Partially purified enzyme was isolated as described under Fig. 3 .  
Results are the mean of duplicate determinations. The hatched 
bars represent enzyme activity without activator, O d ,  l-methyi- 
3-isobutylxanthine; *---+, papaverine; A-A, theophylline; 
A-A, caffein; ..  ., theobromine 
Table 4. Inhibition ofpartially purifiedphosphodiesierase by I-methyl- 
3-isobutylxanthine, papaverine, theophylline and caffeine 
Experimental conditions were the same as described in Fig.5. 
I,, value is the concentration of inhibitor required to produce 50% 
inhibition of 0.4 pM substrate 
Inhibitor I5 0 
cyclic AMP cyclic GMP 
PM 
1 -Methyl-3-isobutylxanthine 21 7 
Papaverine 24 10 
Theophyiline > 200 40 
Caffeine > 200 > 200 
more than 90% of cyclic GMP phosphodiesterase 
activity was localized in the soluble fraction. However, 
when Triton X-100 (1 %) was included in the reaction 
mixtures, both activities in soluble fractions were 
decreased considerably while detergent showed almost 
no effect on particulate associated enzymes. When 
high-speed sediment fraction was resuspended in the 
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Fig. 6 .  DEAE-cellulose column chromatography of pituitary phos- 
phodiesiera.re.r. Experimental details are given in Materials and 
Methods. (O.... 0) Without activator; (.-) with activator 
(28 pg) + CaCl, (100 pM). (A) Cyclic AMP (0.4 pM); (B) cyclic 
GMP (0.4 pM); and (C) cyclic AMP (100 pM). (-.-.-.) Sodium 
acetate gradient; (A----A) absorbance at 280 nm 
presence of the detergent and then centrifuged at 
105000 x g (60 min) almost all of the activity seen in 
the original sediment remained in the soluble fraction. 
Addition of protein activator and CaC1, in the incuba- 
tion medium increased the enzyme activity in almost 
all fractions particularly when cyclic AMP was 
the substrate (Table 6). 
Gel Filtrations 
Further comparative characterization of soluble 
and particulate associated enzymes was carried out 
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Table 5. Effect of different activators on the peak II  phosphodiesterase activity 
Peak I and peak I1 phosphodiesterase activities were separated by DEAE-cellulose colum chromatography as described in the text. 
Active fractions from peak I1 were used in the present studies. The activities were determined either in the absence or presence of brain activator 
(28 pg protein) or pituitary activator (15 pg protein). Results are mean of duplicate experiments 
Substrate Concn Activity with 
no activator brain Activator pituitary activator 
PM pmol hydrolysed/min 
Cyclic AMP 0.4 
Cyclic GMP 0.4 










Table 6. Effect of Triton X-I00 on uctivity and solubilizatiun of cyclic nucleotide phosphodiesterase from rat anterior pituitary 
Forty pituitaries were homogenized in 5 ml of buffer A (20 mM Tris-HC1, pH 7.4; 10mM KCI; 10 mM NaCl; 1 mM MgCI,; 
3.75 mM 2-mercaptoethanol) and centrifuged at 105000 x g for 60 min. The supernatant a fluid was removed and 105000 x g 
sediment was washed and either resuspended in buffer (sediment a) or resuspended in buffer A containing 1% Triton X-100, 
centrifuged at 105000 x g for 1 h, the supernatant b removed, the sediment washed with buffer A and finally resuspended in buffer A 
(sediment b). 20-40-pI aliquots of each fraction were assayed for cyclic AMP and cyclic GMP phosphodiesterase activities in the presence 
or absence of Triton X-100 (1%). Activator+CaCI, as indicated. Other details were the same as described under the Methods. 
Values are the mean of duplicate determinations 
~ 
Material Fraction used Cyclic nucleotide hydrolyzed with 
for enzyme assay 
no Triton X-100 activator activator 




A. Cyclic A M P  
1, Tissue whole homogenate 
supernatant a 
sediment a 
2. Sediment a supernatant b 
sediment b 
B. CyclicGMP 
1. Tissue whole homogenate 
supernatant a 
sediment a 
2. Sediment a supernatant b 









































by gel filtration. When whole 40000 x g supernatant 
prepared in the presence of I>< Triton X-100 was 
applied to a Bio-Gel A-5m column (equilibrated with 
50mM Tris-HC1, pH 7.5, 100mM NaCI, 1 mM 
MgCI,, 3.75 mM 2-mercaptoethanol and 0.1 mM 
EGTA) two peaks of activities were detected with 
cyclic AMP and cyclic GMP as substrates. Filtration 
of particulate enzyme showed a single peak which 
coincided with the first peak of the whole homogenate. 
Similarly particulate free supernatant prepared in the 
absence of Triton X-100 showed a single peak of activ- 
ity following gel filtration. Addition of Triton X-100 
to the elution buffer did not influence the elution 
profile of this enzyme. This peak eluted in the same 
position as was peak I1 of the whole homogenate. 
These results demonstrate that the particulate and 
soluble enzymes have different physical characteristics. 
DISCUSSION 
In the present communication we have attempted 
to characterize rat anterior pituitary phosphodiesterase 
which exist in multiple forms. More than 80 percent of 
cyclic AMP and cyclic GMP hydrolyzing activities 
were localized in particulate free fractions. The particu- 
late enzyme seems to be different from soluble enzyme 
as judged by differences in K ,  values, metal ion 
requirements, activator dependence and elution pat- 
tern from agarose columns. Under our experimental 
conditions we could not solubilize particulate enzyme 
more than 15 - 20 percent by sonication but were able 
to solubilize it completely by detergent treatment. Gel 
filtration studies showed that the particulate and 
soluble enzymes differ in physical properties sug- 
gesting that the apparent subcellular distribution 
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seen in Table 6 was not due to adsorption of soluble 
enzyme to particulate material during the isolation 
process. 
The anterior pituitary was also rich in cyclic 
nucleotide phosphodiesterase activator protein. As 
shown in Tables 3 and 5, the extent of stimulation of 
cyclic nucleotide phosphodiesterases by the activator 
was comparable to that reported by Cheung [16] and 
Kakuichi etal. [17] when the activities were assayed 
in the presence of Ca-EGTA buffer [17]. However, 
when the enzyme assays were carried out in the absence 
of EGTA, the extent of stimulation by the activator 
was not as pronounced as that seen in the presence of 
EGTA. This phenomenon can simply be explained on 
the basis that the enzyme preparations used after gel 
filtration may still contain enough endogenous 
activator. This possibility was further strengthened by 
the observation that DEAE-cellulose-purified peak I1 
enzyme was stimulated five - six-fold even in the 
absence of EGTA which was devoid of most of the 
endogenous activator. The activation of enzyme seems 
to be dependent on the presence of divalent metal ions. 
In other systems, Ca” has been shown to be 
required for the interaction of activator with phos- 
phodiesterases [18,27 -291. In the present system, 
Ca2+ failed to exhibit any stimulatory effect either by 
itself or to potentiate the stimulatory effect of activator. 
However, Ca2+ did reverse the inhibitory action of 
EGTA when added along with EGTA or after the 
EGTA treatment of the enzyme suggesting that Ca2+ 
is involved in the regulation of phosphodiesterases. 
Somewhat similar observations have been made for 
phosphodiesterase activities from pig coronary arteries 
[30]. These data also do not preclude the possibility 
that the anterior pituitary contains both Ca2 +-depend- 
ent and independent forms of cyclic AMP phos- 
phodiesterase(s). Further, there is a possibility that 
the activator preparations employed in our studies still 
contained a small amount of firmly bound Ca2+ even 
after its dialysis against buffer containing EGTA [31]. 
In addition, although deionized water or in some cases 
Ca2+-EGTA buffer was used to follow Ca2+ effect, we 
cannot rule out the possibility that some of the 
solutions employed had enough Ca” to activate 
phosphodiesterase activity. 
The partially purified (gel filtration) pituitary cyclic 
nucleotide phosphodiesterase showed more activity 
with cyclic GMP compared to cyclic AMP when 
activities were assayed in the presence of sub-saturating 
concentrations of substrate. These results are com- 
parable to those reported for heart, brain and liver 
enzymes [l, 131. In the pituitary, like heart and 
cerebellum [13], cyclic GMP hydrolyzing enzyme 
accounted for more than 80% total cyclic nucleotide 
hydrolyzing activity. Following gel filtration, the peak 
activity fraction hydrolyzed cyclic GMP to a greater 
extent compared to cyclic AMP but activity increased 
with increasing concentrations of cyclic AMP and at 
saturating concentration, it hydrolyzed cyclic AMP 
at a faster rate than cyclic GMP probably because the 
tissue concentrations of cyclic AMP are far greater 
than cyclic GMP [32,33]. 
It is now believed that cyclic nucleotide phos- 
phodiesterase exists in multi-molecular forms [2,3,6, 
10,34 -431. Cyclic nucleotide phosphodiesterases from 
rat brain, heart, skeletal muscle, kidney and adipose 
tissue have been separated into two forms by gel 
filtration [2,3,10,11]. However, in the present studies 
only one peak of activity was observed with both 
substrates. These differences may be due to the 
experimental conditions including enzyme isolation, 
gel filtration and assay conditions. Further, in most 
of the above instances effects of Ca2+ and activator 
have not been studied. On the contrary, pituitary 
phosphodiesterase could be separated by DEAE- 
cellulose column chromatography into two species 
with different substrate specificities and activator 
dependency. But none of the enzymes seem to be 
specific for cyclic GMP as has been reported in rat 
liver [lo, 111. However, some enzymatic characteristics 
of pituitary enzymes do agree with those of rat liver 
preparations, at least, partially. 
The physiological role of the regulation of these 
phosphodiesterase(s) is currently unknown. It seems 
likely that these enzymes may regulate cyclic AMP 
concentrations in vivo. Since in the pituitary, Ca2 + 
is known to modulate the accumulation of cyclic 
AMP [20] and the present finding that Ca2+ modulates 
phosphodiesterase activity, it is likely that the concen- 
tration of Caz+ and the capacity of activator to bind 
Ca2+ may be one of the determining factors in 
regulating cyclic-AMP-mediated [19] and gonado- 
tropin-induced lutropin release from anterior pituitary. 
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